Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2019

Feb 7, 2019

29745_dirs_2019-02-06_bc6b6c7e-d440-4ca0-a7b8-e48b075082d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-02-04

Reporting Person: Harrington Michael J (Senior VP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-04 Common Stock A 28155 $120.17 Acquired 126299 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-04 Restricted Stock Unit $ A 18765 Acquired 2020-02-01 Common Stock (18765.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 442 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.